Heger, L.* ; Hofer, T.P. ; Bigley, V.* ; de Vries, I.J.M.* ; Dalod, M.* ; Dudziak, D.* ; Ziegler-Heitbrock, L.*
Subsets of CD1c+DCs: Dendritic cell versus monocyte lineage.
Front. Immunol. 11:559166 (2020)
Currently three bona fide dendritic cell (DC) types are distinguished in human blood. Herein we focus on type 2 DCs (DC2s) and compare the three defining markers CD1c, CD172, and CD301. When using CD1c to define DC2s, a CD14(+)and a CD14(-)subset can be detected. The CD14(+)subset shares features with monocytes, and this includes substantially higher expression levels for CD64, CD115, CD163, and S100A8/9. We review the current knowledge of these CD1c(+)CD14(+)cells as compared to the CD1c(+)CD14(-)cells with respect to phenotype, function, transcriptomics, and ontogeny. Here, we discuss informative mutations, which suggest that two populations have different developmental requirements. In addition, we cover subsets of CD11c(+)CD8(-)DC2s in the mouse, where CLEC12A(+)ESAM(low)cells, as compared to the CLEC12A(-)ESAM(high)subset, also express higher levels of monocyte-associated markers CD14, CD3, and CD115. Finally, we summarize, for both man and mouse, the data on lower antigen presentation and higher cytokine production in the monocyte-marker expressing DC2 subset, which demonstrate that the DC2 subsets are also functionally distinct.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Review
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Dc2 ; Cd1c ; Cd172 ; Cd301 ; Cd14 ; Dendritic Cells ; Dc Subsets; Antigen Cross-presentation; Signal-regulatory Protein; Mononuclear Phagocytes; Molecular-cloning; Human Blood; In-vitro; Expression; Macrophage; Receptor; Lectin
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
1664-3224
e-ISSN
1664-3224
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 11,
Heft: ,
Seiten: ,
Artikelnummer: 559166
Supplement: ,
Reihe
Verlag
Frontiers
Verlagsort
Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Immune Response and Infection
PSP-Element(e)
G-502710-001
Förderungen
Wellcome Trust
Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)
Interdisziplinares Zentrum fur Klinische Forschung
Agency national research (ANR)/German Research Foundation programBayresq.Net (Bavarian Ministry of Sciences)
German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)]
Copyright
Erfassungsdatum
2020-10-30